CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

CENTRAL LABORATORIES APPLICATIONS & STUDIES

CENTRAL LABORATORIES PRODUCTS & SERVICES

Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.

Experience higher data quality, retention and participant compliance by providing a truly engaging experience from data submission to reminders, appointment management, telemedicine and more -- from the phone, tablet, or desktop.

TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.

Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.

Signals Clinical streamlines clinical data workflows, reducing the time spent preparing data for analytics. Its comprehensive platform enables the rapid delivery of clinical insights that inform both clinical and operational study decisions.

ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.

Enabling organizations of all sizes to transform their business through better use of technology.

Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.

They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.